Y. Masubuchi et al., SUBSTRATE STEREOSELECTIVITY AND ENANTIOMER ENANTIOMER INTERACTION IN PROPRANOLOL METABOLISM IN RAT-LIVER MICROSOMES, Biochemical pharmacology, 46(10), 1993, pp. 1759-1765
The substrate stereoselectivity and enantiomer/enantiomer interaction
of (S)- and (R)-propranolol for the formation of their metabolites wer
e investigated in rat liver microsomal fractions. The enantiomers of p
rimary metabolites of propranolol, 4-, 5-, 7-hydroxy- and N-desisoprop
yl-propranolol were separated and assayed by an HPLC method employing
a chiral ovomucoid column. Regioselective substrate stereoselectivity
(R < S for 4- and 5-hydroxylations; R > S for 7-hydroxylation; R = S f
or N-desisopropylation) was observed in the formation of propranolol m
etabolites when the individual enantiomers or a racemic mixture of pro
pranolol were used as substrates. Concentration-dependent metabolic in
hibition of propranolol enantiomers by their optical isomers was also
observed. In addition, the inhibition of propranolol 4-, 5- and 7-hydr
oxylations between the enantiomers showed a typical competitive nature
. These findings suggested that the propranolol enantiomers competed f
or the same enzyme, probably a cytochrome P450 isozyme in the CYP2D su
bfamily.